English High Court grants Fujifilm declaration in AbbVie patent row

08-03-2016

English High Court grants Fujifilm declaration in AbbVie patent row

Andrey_Popov / Shutterstock.com

The English High Court has allowed Japan-based drug maker Fujifilm Kyowa Kirin Biologics to amend some of its arguments in a patent dispute surrounding AbbVie’s arthritis drug Humira (adalimumab).


AbbVie, Fujifilm Kyowa Kirin Biologics, biosimilar, English High Court, patent infringement, Mr Justice Henry Carr, Humira, adalimumab

LSIPR